Synergy Chc Corp Financials

SNYR

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

Financial Health Signals

Altman Z-Score Distress

-0.52

Synergy Chc Corp scores -0.52, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($18.3M) relative to total liabilities ($33.0M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Piotroski F-Score Neutral

4/9

Synergy Chc Corp passes 4 of 9 financial strength tests. 1 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

-2.26x

For every $1 of reported earnings, Synergy Chc Corp generates $-2.26 in operating cash flow (-$4.8M OCF vs $2.1M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage Adequate

3.8x

Synergy Chc Corp earns $3.8 in operating income for every $1 of interest expense ($5.8M vs $1.5M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

This page shows Synergy Chc Corp (SNYR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

$30.0M

YoY-29.9%

5Y CAGR-2.9%

Synergy Chc Corp generated $30.0M in revenue in fiscal year 2024. This represents a decrease of 29.9% from the prior year.

EBITDA

$5.9M

YoY-45.3%

5Y CAGR+7.7%

Synergy Chc Corp's EBITDA was $5.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 45.3% from the prior year.

Free Cash Flow

N/A

Net Income

$2.1M

YoY-66.5%

Synergy Chc Corp reported $2.1M in net income in fiscal year 2024. This represents a decrease of 66.5% from the prior year.

EPS (Diluted)

$0.28

YoY-67.4%

Synergy Chc Corp earned $0.28 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 67.4% from the prior year.

Cash & Debt

$688K

YoY+8.8%

5Y CAGR-22.9%

Synergy Chc Corp held $688K in cash against $7.5M in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

YoY+18.0%

Synergy Chc Corp had 9M shares outstanding in fiscal year 2024. This represents an increase of 18.0% from the prior year.

Gross Margin

78.8%

YoY+3.8pp

5Y CAGR+8.1pp

Synergy Chc Corp's gross margin was 78.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is up 3.8 percentage points from the prior year.

Operating Margin

19.3%

YoY-5.9pp

5Y CAGR+10.9pp

Synergy Chc Corp's operating margin was 19.3% in fiscal year 2024, reflecting core business profitability. This is down 5.9 percentage points from the prior year.

Net Margin

7.1%

YoY-7.7pp

5Y CAGR+9.4pp

Synergy Chc Corp's net profit margin was 7.1% in fiscal year 2024, showing the share of revenue converted to profit. This is down 7.7 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

SNYR Income Statement

Metric	FY24	FY23	FY19	FY18	FY17	FY16
Revenue	$30.0M-29.9%	$42.8M+45.7%	$29.4M-13.2%	$33.8M-5.0%	$35.6M+2.2%	$34.8M
Cost of Revenue	$11.2M+4.6%	$10.7M+17.1%	$9.1M-17.2%	$11.0M+12.4%	$9.8M-3.8%	$10.2M
Gross Profit	$23.6M-26.3%	$32.1M+58.7%	$20.2M-11.3%	$22.8M-11.6%	$25.8M+4.6%	$24.6M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$4.7M-22.1%	$6.1M+10.2%	$5.5M-23.6%	$7.2M-14.6%	$8.4M+5.0%	$8.0M
Operating Income	$5.8M-46.3%	$10.8M+235.8%	-$8.0M-61.8%	-$4.9M-369.9%	$1.8M-37.9%	$2.9M
Interest Expense	$1.5M-8.7%	$1.7M	N/A	$1.1M+8.5%	$1.0M+166.6%	-$1.6M
Income Tax	$102K-56.6%	$235K+278.6%	-$132K-153.1%	$248K-21.6%	$316K-66.5%	$944K
Net Income	$2.1M-66.5%	$6.3M+168.8%	-$9.2M-49.5%	-$6.2M-1333.2%	$500K+162.7%	-$796K
EPS (Diluted)	$0.28-67.4%	$0.86	$-0.10-42.9%	$-0.07-800.0%	$0.01	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	$8.0M-1.5%	$8.1M-72.9%	$30.0M+451.8%	$5.4M-32.2%	$8.0M-14.7%	$9.4M	N/A	$10.8M
Cost of Revenue	$2.3M+22.8%	$1.9M-5.5%	$2.0M-46.8%	$3.8M+53.9%	$2.4M-7.1%	$2.6M	N/A	$3.0M
Gross Profit	$5.7M-8.9%	$6.2M+1.2%	$6.2M-5.2%	$6.5M+16.6%	$5.6M-17.7%	$6.8M	N/A	$7.8M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$1.6M+7.8%	$1.5M+16.3%	$1.3M+3.1%	$1.3M+40.3%	$904K-33.0%	$1.3M	N/A	$1.3M
Operating Income	$1.3M-21.2%	$1.6M-16.6%	$1.9M+43.4%	$1.4M-14.2%	$1.6M-12.4%	$1.8M	N/A	$2.1M
Interest Expense	$1.2M-44.8%	$2.1M+469.7%	$370K+4659.4%	$8K-99.0%	$746K+80.0%	$414K	N/A	$447K
Income Tax	-$11K-105.8%	$190K+1758.9%	-$11K+6.0%	-$12K-106.8%	$179K+41.0%	$127K	N/A	-$13K
Net Income	$125K-91.5%	$1.5M+68.1%	$876K+729.3%	$106K-83.9%	$655K+12.9%	$581K	N/A	$1.3M
EPS (Diluted)	$0.01-94.1%	$0.17+70.0%	$0.10	$0.00-100.0%	$0.09+12.5%	$0.08	N/A	$0.17

SNYR Balance Sheet

Metric	FY24	FY23	FY19	FY18	FY17	FY16
Total Assets	$16.3M+33.5%	$12.2M+135.8%	$5.2M-74.1%	$20.0M-16.7%	$24.0M+17.5%	$20.5M
Current Assets	$16.1M+35.8%	$11.8M+134.3%	$5.0M-43.5%	$8.9M-14.2%	$10.4M+43.4%	$7.3M
Cash & Equivalents	$688K+8.8%	$633K-48.3%	$1.2M+166.4%	$460K-76.5%	$2.0M-22.3%	$2.5M
Inventory	$1.7M-53.9%	$3.7M+100.2%	$1.9M-30.3%	$2.7M-6.1%	$2.8M+157.7%	$1.1M
Accounts Receivable	$5.3M+152.6%	$2.1M+47.9%	$1.4M-68.1%	$4.5M+2.9%	$4.3M+97.4%	$2.2M
Goodwill	N/A	N/A	N/A	$7.8M0.0%	$7.8M0.0%	$7.8M
Total Liabilities	$33.0M-16.6%	$39.5M+280.5%	$10.4M-35.2%	$16.0M+9.9%	$14.6M+9.3%	$13.4M
Current Liabilities	$17.2M+22.6%	$14.0M+38.2%	$10.1M-2.5%	$10.4M+45.9%	$7.1M-41.6%	$12.2M
Long-Term Debt	$7.5M-43.1%	$13.1M	N/A	N/A	N/A	N/A
Total Equity	-$16.6M+39.1%	-$27.3M-424.8%	-$5.2M-231.0%	$4.0M-57.9%	$9.4M+32.7%	$7.1M
Retained Earnings	-$44.1M+4.6%	-$46.2M-90.7%	-$24.2M-61.3%	-$15.0M-69.5%	-$8.9M+5.3%	-$9.4M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$20.7M+4.9%	$19.7M+26.0%	$15.7M-4.2%	$16.3M	N/A	N/A	$12.2M	N/A
Current Assets	$20.5M+5.1%	$19.5M+26.6%	$15.4M-4.1%	$16.1M	N/A	N/A	$11.8M	N/A
Cash & Equivalents	$1.0M-31.0%	$1.5M+720.0%	$178K-74.1%	$688K+267.3%	$187K-81.5%	$1.0M+59.8%	$633K+87.2%	$338K
Inventory	$2.1M-9.2%	$2.4M+0.8%	$2.3M+36.7%	$1.7M	N/A	N/A	$3.7M	N/A
Accounts Receivable	$6.8M-3.6%	$7.1M+61.4%	$4.4M-17.7%	$5.3M	N/A	N/A	$2.1M	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$28.9M-9.8%	$32.1M+2.6%	$31.3M-5.1%	$33.0M	N/A	N/A	$39.5M	N/A
Current Liabilities	$3.8M-46.3%	$7.1M-11.6%	$8.1M-53.1%	$17.2M	N/A	N/A	$14.0M	N/A
Long-Term Debt	$25.1M+0.5%	$25.0M+129.2%	$10.9M+46.1%	$7.5M	N/A	N/A	$13.1M	N/A
Total Equity	-$8.3M+33.3%	-$12.4M+20.8%	-$15.6M+6.0%	-$16.6M+35.7%	-$25.9M+2.7%	-$26.6M+2.6%	-$27.3M+8.3%	-$29.8M
Retained Earnings	-$41.6M+0.3%	-$41.8M+3.4%	-$43.2M+2.0%	-$44.1M	N/A	N/A	-$46.2M	N/A

SNYR Cash Flow Statement

Metric	FY24	FY23	FY19	FY18	FY17	FY16
Operating Cash Flow	-$4.8M-1239.0%	$422K-85.7%	$2.9M+125.8%	$1.3M+257.0%	-$831K-113.8%	$6.0M
Capital Expenditures	N/A	N/A	N/A	$129K-15.6%	$153K-49.4%	$302K
Free Cash Flow	N/A	N/A	N/A	$1.2M+219.5%	-$984K-117.2%	$5.7M
Investing Cash Flow	N/A	N/A	N/A	-$198K+89.6%	-$1.9M+18.7%	-$2.3M
Financing Cash Flow	$4.8M+329.8%	-$2.1M-2.0%	-$2.0M+28.4%	-$2.9M-223.9%	$2.3M+147.8%	-$4.8M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	-$2.3M-2901.2%	-$77K+90.6%	-$823K+76.0%	-$3.4M-1115.0%	-$282K+67.1%	-$858K-127.2%	$3.2M	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	$1.9M+42.9%	$1.3M+318.8%	$315K-91.9%	$3.9M+754.4%	-$597K-159.4%	$1.0M+138.0%	-$2.6M	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

SNYR Financial Ratios

Metric	FY24	FY23	FY19	FY18	FY17	FY16
Gross Margin	78.8%+3.8pp	75.0%+6.1pp	68.9%+1.5pp	67.4%-5.0pp	72.4%+1.7pp	70.7%
Operating Margin	19.3%-5.9pp	25.3%+52.4pp	-27.1%-12.6pp	-14.5%-19.7pp	5.1%-3.3pp	8.4%
Net Margin	7.1%-7.7pp	14.8%+46.2pp	-31.4%-13.1pp	-18.2%-19.6pp	1.4%+3.7pp	-2.3%
Return on Equity	N/A	N/A	N/A	N/A	5.3%	N/A
Return on Assets	13.0%-38.8pp	51.8%+229.2pp	-177.4%-146.6pp	-30.8%-32.9pp	2.1%+6.0pp	-3.9%
Current Ratio	0.93+0.1	0.84+0.3	0.50-0.4	0.86-0.6	1.46+0.9	0.59
Debt-to-Equity	-0.45+0.0	-0.48+1.5	-2.00-6.0	4.04+2.5	1.55-0.3	1.88
FCF Margin	N/A	N/A	N/A	3.5%+6.2pp	-2.8%-19.2pp	16.5%

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	70.9%-5.8pp	76.7%+56.1pp	20.5%-46.7pp	67.2%-2.3pp	69.5%-2.5pp	72.0%	N/A	72.0%
Operating Margin	16.0%-4.0pp	20.0%+13.5pp	6.5%-18.5pp	25.0%+5.3pp	19.7%+0.5pp	19.2%	N/A	19.9%
Net Margin	1.6%-16.6pp	18.1%+15.2pp	2.9%+1.0pp	1.9%-6.2pp	8.2%+2.0pp	6.2%	N/A	11.9%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	0.6%-6.9pp	7.5%+1.9pp	5.6%+5.0pp	0.7%	N/A	N/A	N/A	N/A
Current Ratio	5.35+2.6	2.74+0.8	1.91+1.0	0.93	N/A	N/A	0.84	N/A
Debt-to-Equity	-3.04-1.0	-2.02-1.3	-0.70-0.2	-0.45	N/A	N/A	-0.48	N/A
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$16.6M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.93), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Cosmos Health Inc. COSM

$13.9M

Zynex Inc ZYXI

$3.8M

111 YI

$68.0M

Quipt Home Medical Corp QIPT

$158.7M

Edap Tms EDAP

$178.4M

Frequently Asked Questions

What is Synergy Chc Corp's annual revenue?

Synergy Chc Corp (SNYR) reported $30.0M in total revenue for fiscal year 2024. This represents a -29.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Synergy Chc Corp's revenue growing?

Synergy Chc Corp (SNYR) revenue declined by 29.9% year-over-year, from $42.8M to $30.0M in fiscal year 2024.

Is Synergy Chc Corp profitable?

Yes, Synergy Chc Corp (SNYR) reported a net income of $2.1M in fiscal year 2024, with a net profit margin of 7.1%.

What is Synergy Chc Corp's earnings per share (EPS)?

Synergy Chc Corp (SNYR) reported diluted earnings per share of $0.28 for fiscal year 2024. This represents a -67.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Synergy Chc Corp's EBITDA?

Synergy Chc Corp (SNYR) had EBITDA of $5.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Synergy Chc Corp have?

As of fiscal year 2024, Synergy Chc Corp (SNYR) had $688K in cash and equivalents against $7.5M in long-term debt.

What is Synergy Chc Corp's gross margin?

Synergy Chc Corp (SNYR) had a gross margin of 78.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Synergy Chc Corp's operating margin?

Synergy Chc Corp (SNYR) had an operating margin of 19.3% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Synergy Chc Corp's net profit margin?

Synergy Chc Corp (SNYR) had a net profit margin of 7.1% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Synergy Chc Corp's operating cash flow?

Synergy Chc Corp (SNYR) generated -$4.8M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Synergy Chc Corp's total assets?

Synergy Chc Corp (SNYR) had $16.3M in total assets as of fiscal year 2024, including both current and long-term assets.

How many shares does Synergy Chc Corp have outstanding?

Synergy Chc Corp (SNYR) had 9M shares outstanding as of fiscal year 2024.

What is Synergy Chc Corp's current ratio?

Synergy Chc Corp (SNYR) had a current ratio of 0.93 as of fiscal year 2024, which is below 1.0, which may suggest potential liquidity concerns.

What is Synergy Chc Corp's debt-to-equity ratio?

Synergy Chc Corp (SNYR) had a debt-to-equity ratio of -0.45 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Synergy Chc Corp's return on assets (ROA)?

Synergy Chc Corp (SNYR) had a return on assets of 13.0% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Synergy Chc Corp's cash runway?

Based on fiscal year 2024 data, Synergy Chc Corp (SNYR) had $688K in cash against an annual operating cash burn of $4.8M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Synergy Chc Corp's debt-to-equity ratio negative or unusual?

Synergy Chc Corp (SNYR) has negative shareholder equity of -$16.6M as of fiscal year 2024, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Synergy Chc Corp's Altman Z-Score?

Synergy Chc Corp (SNYR) has an Altman Z-Score of -0.52, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Synergy Chc Corp's Piotroski F-Score?

Synergy Chc Corp (SNYR) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Synergy Chc Corp's earnings high quality?

Synergy Chc Corp (SNYR) has an earnings quality ratio of -2.26x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Synergy Chc Corp cover its interest payments?

Synergy Chc Corp (SNYR) has an interest coverage ratio of 3.8x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.